Skip to main content
. 2023 Jan 6;13:1030104. doi: 10.3389/fpsyg.2022.1030104

Table 2.

Baseline characteristics of participants.

Intervention group n = 30 Control group n = 30 t/χ 2 P
Age (M ± SD) 84.23 ± 7.07 83.40 ± 7.29 0.449 0.655
Gender (n, %)
 Male 9 (30.0%) 7 (23.3%) 0.341 0.559
 Female 21 (70.0%) 23 (76.7%)
Education (n, %)
 Junior high school or below 5 (16.7%) 10 (33.3%) 2.424 0.298
 High school 6 (20.0%) 6 (20.0%)
 College degree or above 19 (63.3%) 14 (46.7%)
Number of children (M ± SD) 2.37 ± 1.07 2.20 ± 1.03 0.616 0.541
Visit frequency by children (n, %)
 <1 time/month 5 (16.7%) 7 (23.3%) 3.167 0.367
 1 time/month 8 (26.7%) 4 (13.3%)
 2–4 times/month 13 (43.3%) 11 (36.7%)
 >5 times/month 4 (13.3%) 8 (26.7%)
Number of diseases (M ± SD) 2.97 ± 0.62 2.63 ± 0.77 1.860 0.068
Drug usage (n, %)
 Yes 28 (93.3%) 25 (83.3%) 0.647 0.421
 No 2 (6.7%) 5 (16.7%)
Participation in group activities (n, %)
 Yes 11 (36.7%) 15 (50.0%) 1.086 0.297
 No 19 (63.3%) 15 (50.0%)
Stay in a nursing home (n, %)
 <6 months 7 (23.3%) 6 (20.0%) 2.359 0.501
 6–12 months 3 (10.1%) 7 (23.3%)
 1–2 years 4 (13.3%) 5 (16.7%)
 >2 years 16 (53.3%) 12 (40.0%)
Depression score(M ± SD) 9.40 ± 2.01 9.33 ± 2.37 0.118 0.907
Positive coping(M ± SD) 20.38 ± 3.61 20.68 ± 3.16 −0.332 0.741
Negative coping(M ± SD) 14.07 ± 2.91 14.37 ± 2.92 −0.399 0.692
Self-efficacy score(M ± SD) 24.50 ± 6.11 24.13 ± 5.99 0.235 0.815